HHS releases initial guidance for Medicare prescription drug inflation rebate program

CMS

9 February 2023 - Under President Biden’s prescription drug law, drug companies will pay rebates to the federal government for raising prescription drug prices faster than the rate of inflation

As part of President Biden’s historic Inflation Reduction Act, the nation’s new prescription drug law, for the first time ever, drug companies will pay rebates to Medicare when their prescription drug prices increase faster than the rate of inflation for certain drugs dispensed to people with Medicare.

Read CMS press release

Michael Wonder

Posted by:

Michael Wonder

Posted in:

US , Regulation , Medicare , Pricing